-2.3 C
New York
Wednesday, March 18, 2026
HomeHealth

Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don't sweat Novo Nordisk's head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about...

Hidden factor in cancer treatment timing may affect survival, researchers say

NEWYou can now listen to Fox News articles! The time of day patients receive cancer treatments could have an impact on the...

FDA Approves First Oral GLP-1 Pill for Weight Loss – SUCH TV

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to...

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump's move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot...

Here’s how much ACA premiums would have risen this year without tax subsidies

Millions of Americans are bracing for higher health costs in 2026, as subsidies that help them pay for health insurance...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read